Walking in their shoes - psychiatrists experience the virtual reality of schizophrenia

September 10, 2000

[11 September 2000, Munich] -- Janssen Pharmaceutica today unveiled Paved with Fear, using state of the art technology to simulate the experience of having schizophrenia. This "virtual hallucination" booth is designed to help psychiatrists and other healthcare professionals understand their patients' experiences first hand.

"For any physician, the goal is to have the most accurate representation of a patient's symptoms in order to treat them most effectively," said consultant psychiatrist Dr Marc de Hert, who worked as a medical advisor on Paved with Fear. "Therefore, we worked closely with many patients to develop a virtual hallucination which demonstrates at a practical level exactly what they endure on a daily basis."

The virtual reality experience takes the participant through everyday activities, using sound, video and movement to bring to life the impact of auditory and visual hallucinations. Each journey through the Paved with Fear experience is unique and tailored to the individual participating.
-end-
For further information, please contact:

Melissa Katz, Janssen Pharmaceutica:
00-32-7596-5263
Roseann Ward, Ketchum:
00-44-7932-798-151
John Gisborne, Ketchum:
00-44-20-7465-8753
Tamsin Page, Ketchum:
00-44-20-7465-7688
tamsin.page@ketchumcomms.co.uk

Note to Editors:

Janssen Pharmaceutica is headquartered in Beerse, Belgium. Risperdal™ is marketed globally by Janssen-Cilag, and in partnership with NV Organon in the European Union (except for Italy, Spain and Finland, where it is marketed by Janssen-Cilag only), Norway, Switzerland, Brazil and Argentina. Janssen Pharmaceutica has been a member of the Johnson & Johnson family of companies since 1961. Johnson & Johnson is the world's largest and most comprehensive manufacturer of healthcare products, serving the pharmaceutical, professional and consumer markets.

Ketchum UK

Related Schizophrenia Articles from Brightsurf:

Schizophrenia: When the thalamus misleads the ear
Scientists at the University of Geneva (UNIGE) and the Synapsy National Centre of Competence in Research (NCCR) have succeeded in linking the onset of auditory hallucinations - one of the most common symptoms of schizophrenia - with the abnormal development of certain substructures of a region deep in the brain called the thalamus.

Unlocking schizophrenia
New research, led by Prof. LIU Bing and Prof. JIANG Tianzi from the Institute of Automation of the Chinese Academy of Sciences and their collaborators have recently developed a novel imaging marker that may help in the personalized medicine of psychiatric disorders.

Researchers discover second type of schizophrenia
In a study of more than 300 patients from three continents, over one third had brains that looked similar to healthy people.

New clues into the genetic origins of schizophrenia
The first genetic analysis of schizophrenia in an ancestral African population, the South African Xhosa, appears in the Jan.

Dietary supplement may help with schizophrenia
A dietary supplement, sarcosine, may help with schizophrenia as part of a holistic approach complementing antipsychotic medication, according to a UCL researcher.

Schizophrenia: Adolescence is the game-changer
Schizophrenia may be related to the deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms.

Study suggests overdiagnosis of schizophrenia
In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clinic with a schizophrenia diagnosis didn't actually have schizophrenia.

The ways of wisdom in schizophrenia
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.

Recognizing the uniqueness of different individuals with schizophrenia
Individuals diagnosed with schizophrenia differ greatly from one another. Researchers from Radboud university medical center, along with colleagues from England and Norway, have demonstrated that very few identical brain differences are shared amongst different patients.

Resynchronizing neurons to erase schizophrenia
Today, a decisive step in understanding schizophrenia has been taken.

Read More: Schizophrenia News and Schizophrenia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.